{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T06:30:36Z","timestamp":1765866636636,"version":"3.48.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:p>\n                    TNBC is an aggressive and various subtype of breast cancer, notable by the lack of specific oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), consequential in limited treatment options and poor prognosis. Kinesin Family Member C1 (KIFC1), a mitotic motor protein critical for centrosome clustering and spindle formation, has critical role in TNBC progress. In this situation, natural compounds were explored as probable inhibitors of this protein. we utilized molecular docking, ADMET profiling, density functional theory calculations, molecular dynamics simulations, MM\/GBSA binding free energy analysis, and principal component analysis to thoroughly evaluate binding affinity, stability, and drug-likeness property of natural compounds against KIFC1. Of the 36,900 compounds utilized, five natural compounds were carefully chosen for further assessment. All five compounds Fosfocytocin, Molybdopterin Compound Z, 5-amino-2-(3-hydroxy-13-methyltetradecanamido) pentanoic acid, TMC-52A, and Muscimol exhibited significant inhibitory efficacy against KIFC1. These compounds demonstrated persistent interactions with critical residues and had advantageous binding properties in computational evaluations. The results collectively indicate their potential as effective inhibitors for targeting KIFC1 in forthcoming studies. These data collectively identify all five natural compounds as possible inhibitors of KIFC1. Nonetheless, their effectiveness and safety must be confirmed through\n                    <jats:italic>in vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vitro<\/jats:italic>\n                    study prior to consideration for clinical application.\n                  <\/jats:p>","DOI":"10.3389\/fbinf.2025.1689172","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T06:26:08Z","timestamp":1765866368000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico identification of novel natural compounds as potential KIFC1 inhibitors for the therapeutic intervention of triple-negative breast cancer"],"prefix":"10.3389","volume":"5","author":[{"given":"Prashant Kumar","family":"Tiwari","sequence":"first","affiliation":[]},{"given":"Mukesh","family":"Kumar","sequence":"additional","affiliation":[]},{"given":"Richa","family":"Mishra","sequence":"additional","affiliation":[]},{"given":"Xiaomeng","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100871","DOI":"10.1016\/j.chphi.2025.100871","article-title":"Unveiling the therapeutic role of penfluridol and BMS-754,807: NUDT5 inhibition in breast cancer","volume":"10","author":"AlFayi","year":"2025","journal-title":"Chem. Phys. Impact"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0324678","DOI":"10.1371\/journal.pone.0324678","article-title":"KIFC1 inhibition: exploring the potential of propolis-derived small molecules for targeting cancer progression through in silico analysis","volume":"20","author":"Azmi","year":"2025","journal-title":"PLOS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","article-title":"ProTox-II: a webserver for the prediction of toxicity of chemicals","volume":"46","author":"Banerjee","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.3390\/molecules27144490","article-title":"Evaluation of biological activity of natural compounds: current trends and methods","volume":"27","author":"Barba-Ostria","year":"2022","journal-title":"Molecules"},{"key":"B6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1039\/C5NP00121H","article-title":"The use of isolated natural products as scaffolds for the generation of chemically diverse screening libraries for drug discovery","volume":"33","author":"Barnes","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: a high-performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"Bochevarov","year":"2013","journal-title":"Int. J. Quantum Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1021\/jm000017s","article-title":"Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening","volume":"43","author":"Boehm","year":"2000","journal-title":"J. Med. Chem."},{"key":"B9","first-page":"84","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1002\/ptr.7099","article-title":"Natural products: a lead for drug discovery and development","volume":"35","author":"Chopra","year":"2021","journal-title":"Phytotherapy Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.6004\/jnccn.2016.0018","article-title":"Genetic\/familial high-risk assessment: breast and ovarian, version 2.2015","volume":"14","author":"Daly","year":"2016","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"B13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/molecules29030689","article-title":"Medicinal chemistry strategies for the modification of bioactive natural products","volume":"29","author":"Ding","year":"2024","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.7314\/apjcp.2016.17.4.1973","article-title":"Breast cancer molecular subtypes defined by ER\/PR and HER2 status: association with clinicopathologic parameters in Ivorian patients","volume":"17","author":"Effi","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3390\/app13042403","article-title":"Identification of hub genes associated with breast cancer using integrated gene expression data with protein-protein interaction network","volume":"13","author":"Elbashir","year":"2023","journal-title":"Appl. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"681476","DOI":"10.3389\/fonc.2021.681476","article-title":"Current triple-negative breast cancer subtypes: dissecting the Most aggressive form of breast cancer","volume":"11","author":"Ensenyat-Mendez","year":"2021","journal-title":"Front. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41467-020-20208-x","article-title":"The ATM and ATR kinases regulate centrosome clustering and tumor recurrence by targeting KIFC1 phosphorylation","volume":"12","author":"Fan","year":"2021","journal-title":"Nat. Commun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1093\/nar\/gkt204","article-title":"Kinesin KIFC1 actively transports bare double-stranded DNA","volume":"41","author":"Farina","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/jcb.30214","article-title":"Identification of polypharmacological anticancerous molecules against Aurora kinase family of proteins","volume":"123","author":"Gupta","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"B21","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1080\/07391102.2022.2154849","article-title":"Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy","volume":"41","author":"Hassan","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B22","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/41118","article-title":"Coupling of kinesin steps to ATP hydrolysis","volume":"388","author":"Hua","year":"1997","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.7164\/antibiotics.51.629","article-title":"TMC-52A to D, novel cysteine proteinase inhibitors, produced by gliocladium sp","volume":"51","author":"Isshiki","year":"1998","journal-title":"J. Antibiot."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s11064-014-1245-y","article-title":"Muscimol as an ionotropic GABA receptor agonist","volume":"39","author":"Johnston","year":"2014","journal-title":"Neurochem. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00894-015-2789-8","article-title":"Comparative molecular field analysis and molecular dynamics studies of \u03b1\/\u03b2 hydrolase domain containing 6 (ABHD6) inhibitors","volume":"21","author":"Kaczor","year":"2015","journal-title":"J. Mol. Model"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1039\/D4MD00223G","article-title":"Systematic computational strategies for identifying protein targets and lead discovery","volume":"15","author":"Kataria","year":"2024","journal-title":"RSC Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"28742","DOI":"10.1038\/s41598-025-14503-0","article-title":"Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulations","volume":"15","author":"Khan","year":"2025","journal-title":"Sci. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s001090000084","article-title":"Recent developments in structure-based drug design","volume":"78","author":"Klebe","year":"2000","journal-title":"J. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"13965","DOI":"10.1080\/07391102.2021.1997821","article-title":"Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16)","volume":"40","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1080\/07391102.2023.2220822","article-title":"Identification of small molecule inhibitors of RAD52 for breast cancer therapy: in silico approach","volume":"42","author":"Kumar","year":"","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B31","doi-asserted-by":"publisher","first-page":"100743","DOI":"10.1016\/j.chphi.2024.100743","article-title":"In silico identification of novel CDK4 inhibitors for retinoblastoma","volume":"9","author":"Kumar","year":"","journal-title":"Chem. Phys. Impact"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1391288","DOI":"10.3389\/fcimb.2024.1391288","article-title":"Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19","volume":"14","author":"Kumar Tiwari","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3390\/ijms23042288","article-title":"New and emerging targeted therapies for advanced breast cancer","volume":"23","author":"Lau","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s43556-022-00110-2","article-title":"Targeting the PI3K\/AKT\/mTOR and RAF\/MEK\/ERK pathways for cancer therapy","volume":"3","author":"Li","year":"2022","journal-title":"Mol. Biomed."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1021\/acs.jcim.7b00412","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: a cross-docking study","volume":"57","author":"Liu","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2405611","DOI":"10.1002\/advs.202405611","article-title":"Targeting KIFC1 promotes senescence in soft tissue sarcoma via FXR1-Dependent regulation of MAD2L1 mRNA stability","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.3390\/cancers14174280","article-title":"Challenges for triple negative breast cancer treatment: defeating heterogeneity and cancer stemness","volume":"14","author":"Mahmoud","year":"2022","journal-title":"Cancers"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8324696","DOI":"10.1155\/2018\/8324696","article-title":"Natural products for the management and prevention of breast cancer","volume":"2018","author":"Mitra","year":"2018","journal-title":"Evidence-Based Complementary Altern. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1007\/s11030-024-11026-0","article-title":"Integrated computational approaches for identification of potent pyrazole-based glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) inhibitors: 3D-QSAR, virtual screening, docking, MM\/GBSA, EC, MD simulation studies","volume":"29","author":"Niharika","year":"2024","journal-title":"Mol. Divers"},{"key":"B41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2741\/s544","article-title":"Shy role of natural compounds in preventing and treating breast cancer","volume":"12","author":"Noel","year":"2020","journal-title":"Front. Biosci. Sch. Ed."},{"key":"B42","doi-asserted-by":"publisher","first-page":"15121","DOI":"10.1038\/s41598-017-14754-6","article-title":"Structural basis of small molecule ATPase inhibition of a human mitotic kinesin motor protein","volume":"7","author":"Park","year":"2017","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"114510","DOI":"10.1016\/j.yexcr.2025.114510","article-title":"KIFC1 in cancer: understanding its expression, regulation, and therapeutic potential","volume":"447","author":"Sanghvi","year":"2025","journal-title":"Exp. Cell Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/med.21926","article-title":"Computational benchmarking of putative KIFC1 inhibitors","volume":"43","author":"Sharma","year":"2023","journal-title":"Med. Res. Rev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1242\/jcs.200261","article-title":"Molecular mechanisms of kinesin-14 motors in spindle assembly and chromosome segregation","volume":"130","author":"She","year":"2017","journal-title":"J. Cell Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/nar\/gkad012","article-title":"Structure and functional determinants of Rad6\u2013Bre1 subunits in the histone H2B ubiquitin-conjugating complex","volume":"51","author":"Shukla","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev.physchem.50.1.221","article-title":"Density functional theory of biologically relevant metal centers","volume":"50","author":"Siegbahn","year":"1999","journal-title":"Annu. Rev. Phys. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1089066","DOI":"10.3389\/fphar.2022.1089066","article-title":"Clinical updates on tyrosine kinase inhibitors in HER2-positive breast cancer","volume":"13","author":"Singh","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3390\/cells12040674","article-title":"Recent clinical advances on long non-coding RNAs in triple-negative breast cancer","volume":"12","author":"Singh","year":"2023","journal-title":"Cells"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1455211","DOI":"10.3389\/fimmu.2024.1455211","article-title":"Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer","volume":"15","author":"Singh","year":"2024","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"111982","DOI":"10.1016\/j.cellsig.2025.111982","article-title":"Non-coding RNAs in cancer therapy-induced cardiotoxicity: unlocking precision biomarkers for early detection","volume":"135","author":"Singh","year":"2025","journal-title":"Cell Signal"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3390\/cancers15082204","article-title":"Recent advances with precision medicine treatment for breast cancer including triple-negative sub-type","volume":"15","author":"Subhan","year":"2023","journal-title":"Cancers"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1021\/cb400186w","article-title":"Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1","volume":"8","author":"Wu","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1039\/d4md00786g","article-title":"Distinctive roles of aquaporins and novel therapeutic opportunities against cancer","volume":"16","author":"Yadav","year":"2024","journal-title":"RSC Med. Chem."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3390\/molecules27103060","article-title":"Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase yes (YES1): implications in anticancer therapeutics","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"B56","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.phyplu.2025.100764","article-title":"Identification of possible antimalarial constituent(s) from the leaves of ochna kibbiensis: a phytochemical, in vivo and in silico approaches","volume":"5","author":"Yusuf","year":"2025","journal-title":"Phytomedicine Plus"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1042\/BJ20150992","article-title":"Discovery of a novel inhibitor of kinesin-like protein KIFC1","volume":"473","author":"Zhang","year":"2016","journal-title":"Biochem. J."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1689172\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T06:26:10Z","timestamp":1765866370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1689172\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":57,"alternative-id":["10.3389\/fbinf.2025.1689172"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1689172","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"1689172"}}